Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Samuel Romero
Observed names:
S. Romero,
S. Romero Domínguez
Institutions:
Hospital Universitari i Politècnic La Fe,
Instituto de Investigación Sanitaria La Fe
Observed institutions:
Universitat de València,
Hospital Universitari i Politècnic La Fe,
Complejo Hospitalario de Salamanca,
Centro de Investigación Biomédica en Red de Cáncer,
Instituto de Investigación Sanitaria La Fe
ORCID:
0000-0002-1060-2158
Observed ORCID:
0000-0002-1060-2158
OpenAlex ID:
A5023762547
Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation
2018
·
Samuel Romero
, Juan Montoro
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
58
Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases.
2015
·
Samuel Romero
, Pilar Solves
, et al.
·
PubMed
·
38
Infections of the Central Nervous System after Unrelated Donor Umbilical Cord Blood Transplantation or Human Leukocyte Antigen–Matched Sibling Transplantation
2016
·
Aitana Balaguer Rosello
, Luis Bataller
, et al.
·
Transplantation and Cellular Therapy
·
36
Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain
2020
·
Carmen Martínez
, Cecilia Carpio
, et al.
·
Transplantation and Cellular Therapy
·
28
PDF
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study
2021
·
Maria Stefania Infante
, Ana Fernández‐Cruz
, et al.
·
Cancer Medicine
·
21
PDF
T Cell–Depleted Related HLA-Mismatched Peripheral Blood Stem Cell Transplantation as Salvage Therapy for Graft Failure after Single Unit Unrelated Donor Umbilical Cord Blood Transplantation
2014
·
Federico Moscardó
, Samuel Romero
, et al.
·
Transplantation and Cellular Therapy
·
17
PDF
Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series
2018
·
on behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO cooperative group)
, S. Bobillo
, et al.
·
Annals of Hematology
·
16
Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.
2015
·
Pilar Solves
, Nelly Carpio
, et al.
·
PubMed
·
16
Central Nervous System Involvement in Epstein–Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation
2020
·
Aitana Balaguer-Rosello
, José Luis Piñana
, et al.
·
Transplantation and Cellular Therapy
·
15
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma
2022
·
Carmen Martínez
, Manuel Espeso de Haro
, et al.
·
Annals of Hematology
·
12
Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia
2023
·
José Vicente Gil
, Esperanza Such
, et al.
·
International Journal of Molecular Sciences
·
11
PDF
Guía práctica de tratamiento urgente de la microangiopatía trombótica
2018
·
Samuel Romero
, Amparo Sempere
, et al.
·
Medicina Clínica
·
11
The Addition of Brentuximab Vedotin to ESHAP Significantly Increases the Rate of Metabolic Complete Remissions Vs Chemotherapy Alone. in Patients with Relapsed/Refractory Classical Hodgkin's Lymphoma. Final Results of a Phase IIb Prospective Randomized Clinical Trial (BRESELIBET)
2024
·
Anna Maria Sureda Balarí
, Javier Nuñez Cespedes
, et al.
·
Blood
·
8
Practice guidelines for the emergency treatment of thrombotic microangiopathy
2018
·
Samuel Romero
, Amparo Sempere
, et al.
·
Medicina Clínica (English Edition)
·
8
Outcomes of patients with Hodgkin lymphoma receiving Brentuximab Vedotin (BV) as maintenance therapy after ASCT according to previous exposure to BV. A retrospective analysis of the EBMT Lymphoma Working Party in collaboration with GELTAMO, FIL, LYSA, and Turkish Lymphoma Group
2025
·
Carmen Martínez
, Irma Khvedelidze
, et al.
·
Bone Marrow Transplantation
·
7
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin’s lymphoma: report on three cases and literature review
2021
·
Samuel Romero
, Aitana Balaguer-Roselló
, et al.
·
Therapeutic Advances in Hematology
·
6
Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia
2026
·
Beatriz Martín‐Herreros
, Lourdes Cordón
, et al.
·
Cytometry Part B Clinical Cytometry
·
2
PDF
Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis
2025
·
P. López-Pereira
, S. Romero Domínguez
, et al.
·
Bone Marrow Transplantation
·
2
Real-World Management Patterns of Acute Toxicity Following Bispecific Antibody Therapy for Patients with B-Cell Lymphoma - the Geltamo (Spanish Lymphoma Group) Experience
2024
·
Mariana Bastos-Oreiro
, Gloria Iacoboni
, et al.
·
Blood
·
2
Outcomes of Patients with Hodgkin Lymphoma Receiving Brentuximab Vedotin (BV) As Maintenance Therapy after ASCT According to Previous Exposure to BV. a Retrospective Analysis of the EBMT Lymphoma Working Party in Collaboration with Geltamo, FIL, Lysarc, and Turkish Lymphoma Group
2024
·
Maria Carmen Martinez Munoz
, Irma Khvedelidze
, et al.
·
Blood
·
2
PDF
Lineage switch from B lymphoblastic leukemia with KMT2A -rearranged to mixed-phenotype acute leukemia under daratumumab
2020
·
Javier Marco-Ayala
, Ana Isabel Vicente
, et al.
·
Blood Research
·
2
PDF
Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)
2018
·
Carmen Martinez
, Cecilia Carpio
, et al.
·
Blood
·
2
Post‐transplant monomorphic Burkitt's lymphoma: Clinical characteristics and outcome of a multicenter series
2017
·
S. Bobillo
, P. Abrisqueta
, et al.
·
Hematological Oncology
·
2
PDF
Phenotypic Characterization of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-Cell Lymphocytosis
2026
·
Fernando Martin-Moro
, Miguel Alcoceba
, et al.
·
Modern Pathology
·
1
PDF
Immunotherapy may be preferable to chemotherapy for patients with POD24 follicular lymphoma in the second‐line setting
2026
·
Ángel Serna
, Marc Bosch
, et al.
·
British Journal of Haematology
·
1
Show more works
View as search
Works count:
41
Citation count:
329
H-index:
11
I10-index:
12
Year
Topic
Type